國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Comparative effectiveness in surgica...

Bilimoria, Karl Y.

Comparative effectiveness in surgical oncologykey questions and how to answer them /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Comparative effectiveness in surgical oncologyedited by Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi.
其他題名:	key questions and how to answer them /
其他作者:	Bilimoria, Karl Y.
出版者:	Cham :Springer International Publishing :2015.
面頁冊數:	xv, 259 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	CancerSurgery.
電子資源:	http://dx.doi.org/10.1007/978-3-319-12553-4
ISBN:	9783319125534 (electronic bk.)

Comparative effectiveness in surgical oncologykey questions and how to answer them /
Comparative effectiveness in surgical oncologykey questions and how to answer them /[electronic resource] :edited by Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi. - Cham :Springer International Publishing :2015. - xv, 259 p. :ill. (some col.), digital ;24 cm. - Cancer treatment and research,v.1640927-3042 ;. - Cancer treatment and research ;v. 114..

Approaches to Answering Critical CER Questions -- Leveraging Comparative Effectiveness Research to Improve the Quality of Multidisciplinary Care for Breast Cancer Patients -- Comparative Effectiveness in Melanoma -- Comparative Effectiveness Research for Sarcoma -- Comparative Effectiveness in Thyroid Cancer -- Comparative Effectiveness in Head and Neck Malignancies -- Comparative Effectiveness Issues in Lung Cancer -- Comparative Effectiveness in Esophagogastric Cancer -- Comparative Effectiveness in Colon and Rectal Cancer -- Research Gaps in Pancreatic Cancer Research and Comparative Effectiveness Research Methodologies -- Comparative Effectiveness in Surgical Oncology: Hepatic Malignancies -- Comparative Effectiveness Research in Urologic Cancers -- Comparative Effectiveness Research in Gynecologic Oncology.

Despite tremendous recent advances in the treatment of most malignancies, there remain several critical questions for each cancer. This particularly true for the surgical management of solid-organ malignancies. Comparative effectiveness is a relatively new term which encompasses the age-old concepts of how best to treat cancer patients. Comparative effectiveness is defined as the direct comparison of healthcare interventions to determine which work best for which patients when considering the benefits and risks. The Institute of Medicine has defined comparative effectiveness research (CER) as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. CER is certainly best done with well-conducted randomized controlled trials. Unfortunately, clinical trials are not always feasible owing to the impracticality of conducting the trial, the considerable cost, and the time required to complete the trial. These challenges are even more pronounced with respect to surgical treatment. Thus alternative approaches may need to be considered in order to address pressing questions in the care of the oncology patient. These approaches may include well-conducted retrospective cohort studies from cancer registries and other data sources, decision and cost-effectiveness analyses, and other novel methodologies. This book lays out the current critical questions for each major malignancy and proposes approaches to gain answers to these pressing questions.

ISBN: 9783319125534 (electronic bk.)

Standard No.: 10.1007/978-3-319-12553-4doiSubjects--Topical Terms:

345507
Cancer
--Surgery.

LC Class. No.: RD651

Dewey Class. No.: 616.994059

Comparative effectiveness in surgical oncologykey questions and how to answer them /
LDR:03493nmm a2200325 a 4500 001 461972
003 DE-He213
005 20150924163542.0
006 m d
007 cr nn 008maaau
008 151110s2015 gw s 0 eng d
020 $a 9783319125534 (electronic bk.)
020 $a 9783319125527 (paper)
024 7 $a 10.1007/978-3-319-12553-4 $2 doi
035 $a 978-3-319-12553-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RD651
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.994059 $2 23
090 $a RD651 $b .C737 2015
245 0 0 $a Comparative effectiveness in surgical oncology $h [electronic resource] : $b key questions and how to answer them / $c edited by Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xv, 259 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Cancer treatment and research, $x 0927-3042 ; $v v.164
505 0 $a Approaches to Answering Critical CER Questions -- Leveraging Comparative Effectiveness Research to Improve the Quality of Multidisciplinary Care for Breast Cancer Patients -- Comparative Effectiveness in Melanoma -- Comparative Effectiveness Research for Sarcoma -- Comparative Effectiveness in Thyroid Cancer -- Comparative Effectiveness in Head and Neck Malignancies -- Comparative Effectiveness Issues in Lung Cancer -- Comparative Effectiveness in Esophagogastric Cancer -- Comparative Effectiveness in Colon and Rectal Cancer -- Research Gaps in Pancreatic Cancer Research and Comparative Effectiveness Research Methodologies -- Comparative Effectiveness in Surgical Oncology: Hepatic Malignancies -- Comparative Effectiveness Research in Urologic Cancers -- Comparative Effectiveness Research in Gynecologic Oncology.
520 $a Despite tremendous recent advances in the treatment of most malignancies, there remain several critical questions for each cancer. This particularly true for the surgical management of solid-organ malignancies. Comparative effectiveness is a relatively new term which encompasses the age-old concepts of how best to treat cancer patients. Comparative effectiveness is defined as the direct comparison of healthcare interventions to determine which work best for which patients when considering the benefits and risks. The Institute of Medicine has defined comparative effectiveness research (CER) as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. CER is certainly best done with well-conducted randomized controlled trials. Unfortunately, clinical trials are not always feasible owing to the impracticality of conducting the trial, the considerable cost, and the time required to complete the trial. These challenges are even more pronounced with respect to surgical treatment. Thus alternative approaches may need to be considered in order to address pressing questions in the care of the oncology patient. These approaches may include well-conducted retrospective cohort studies from cancer registries and other data sources, decision and cost-effectiveness analyses, and other novel methodologies. This book lays out the current critical questions for each major malignancy and proposes approaches to gain answers to these pressing questions.
650 0 $a Cancer $x Surgery. $3 345507
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Oncology. $3 195181
650 2 4 $a Surgery. $3 274153
700 1 $a Bilimoria, Karl Y. $3 714454
700 1 $a Minami, Christina A. $3 714455
700 1 $a Mahvi, David M. $3 714456
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Cancer treatment and research ; $v v. 114. $3 452091
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-12553-4
950 $a Medicine (Springer-11650)